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Introduction
Duchenne muscular dystrophy (DMD) is a relatively common 
inborn error, caused by lack of dystrophin in the membrane 
cytoskeleton of muscle fibers (Hoffman et al., 1987). Myofibers 
show increased plasma membrane instability and can undergo 
cell death (necrosis) either individually or in groups. Necrotic 
myofibers are able to regenerate within the preexisting basal 
lamina through satellite cell activation, myoblast proliferation, 
fusion, and maturation—a process that takes 2 wk. Robust re-
generation is seen in young DMD patient muscle as well as 
dystrophin-deficient dogs, mice, cats, and pigs (Chen et al., 2005; 
Kornegay et al., 2012a; Klymiuk et al., 2013). Successful regen-
eration is associated with retained muscle function at a young 
age. However, as a DMD patient ages, muscle regeneration 
gradually fails, with endomysial fibrosis and fatty replacement 
of the muscle. The fibrofatty infiltration is typically commensu-
rate with muscle wasting and loss of muscle function. Some 
muscles in both dystrophin-deficient DMD patients and dogs, 
such as the extraocular muscles and sartorius, seem able to main-
tain regeneration and are functionally spared (Kornegay et al., 
2012b; Nghiem et al., 2013). Most dystrophin-deficient muscles 
in cats and mice are able to successfully regenerate throughout 
the normal life span (Gaschen et al., 1992). The failed regeneration 
seen in the DMD muscle has features that are shared with aging 
muscle, including chronic inflammatory state and loss of mito-
chondrial function (Baron et al., 2011). However, the age-, mus-
cle-, and species-specific progressions from successful to failed 
regeneration are poorly understood, and there has not been a 
unifying model able to explain the observed transition to muscle 
wasting and the loss of muscle function (Serrano et al., 2011).
We sought to determine the mechanisms under­lying failure of muscle regeneration that is observed in dystrophic muscle through hy­
pothesis generation using muscle profiling data (human 
dystrophy and murine regeneration). We found that trans­
forming growth factor –centered networks strongly asso­
ciated with pathological fibrosis and failed regeneration 
were also induced during normal regeneration but at dis­
tinct time points. We hypothesized that asynchronously re­
generating microenvironments are an underlying driver of 
fibrosis and failed regeneration. We validated this hypothe­
sis using an experimental model of focal asynchronous 
bouts of muscle regeneration in wild­type (WT) mice. A 
chronic inflammatory state and reduced mitochondrial 
oxidative capacity are observed in bouts separated by 
4 d, whereas a chronic profibrotic state was seen in bouts 
separated by 10 d. Treatment of asynchronously remodel­
ing WT muscle with either prednisone or VBP15 mitigated 
the molecular phenotype. Our asynchronous regenera­
tion model for pathological fibrosis and muscle wasting 
in the muscular dystrophies is likely generalizable to tissue 
failure in chronic inflammatory states in other regenera­
tive tissues.
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of differentially regulated genes (Bakay et al., 2002; Seo et al., 
2004, 2006; Irizarry et al., 2005). We reasoned that increased 
sensitivity for selection of differentially regulated genes could 
be obtained by using multiple probe set algorithms, multiple 
microarrays (e.g., U133A and U133B arrays on the same sam-
ples), and multiple queries of existing literature for biochemical 
pathways (Fig. S1). Such an iterative approach would be ex-
pected to greatly increase sensitivity of gene selection but also 
increase false positives. However, using an integrative approach 
with a composite score of gene selection and associated net-
works, we could decrease false positives by focusing on the top-
ranked composite networks (Fig. S1). In effect, as different 
sources of data are assembled to derive a probability determin-
ing the specificity of a network, the most highly scored net-
works have considerable statistical power and significance.
To our knowledge, this two-tier composite approach has 
not been previously described. This approach would be expected 
to be most effective on larger and more complex datasets, and 
for this reason, we used a human 12-disease group, 117-biopsy 
dataset, and 234-microarray dataset as a dataset for model gen-
eration, with multiple validation and model extension datasets.
Visualization of domain knowledge identifies 
a potential disease grouping by the 
histological phenotype of fibrosis and  
failed regeneration
Seven heat maps with clear patterns of association of disease 
groups were generated and visually inspected for possible shared 
pathogenesis between the clustered disease groups. Many of the 
disease groupings were expected and were not studied further. 
For example, juvenile dermatomyositis (JDM) is classified as 
an autoimmune disorder and shows extensive inflammation 
(immune cells) infiltrating the muscle (Tezak et al., 2002; Chen 
et al., 2008). Indeed, a strong clustering of JDM distinct from 
all other disorders was seen with both A and B chips and all 
probe set algorithms, and the members of this cluster were tran-
scripts involved in immune cell infiltration (unpublished data). 
Likewise, most muscular dystrophies show some degeneration 
and regeneration of myofibers, and these gene clusters were 
evident as a recapitulation of embryonic developmental pro-
grams (unpublished data).
One particular grouping of the seven primary heat maps 
was believed to be particularly interesting based upon domain 
knowledge and was studied in some depth (Fig. 1 A). This 
grouping showed a strong up-regulation of transcripts in three 
disorders: DMD, JDM, and ED-D (Emery–Dreifuss muscular 
dystrophy autosomal dominant; LMNA [lamin A/C] mutations). 
The same cluster was up-regulated, but to a lesser extent, in Becker 
muscular dystrophy (BMD; dystrophin mutation), LGMD2A 
(limb girdle muscular dystrophy type 2A; CALP3 [calpain 3] 
mutation), and LGMD2B (limb girdle muscular dystrophy type 
2B; DYSF [dysferlin] mutation). The clustering was seen for 
the A microarray and PLIER (Probe Logarithmic Intensity 
Error) probe set algorithm (Fig. 1, heat map) and also all other 
applied probe set algorithms (not depicted). This grouping 
could be potentially significant, as these three disorders often 
The gradual loss of muscle tissue and disorganization of 
muscle structure in most muscles in a DMD patient has been 
attributed, in part, to a progressive exhaustion of satellite cell 
function in response to the chronic drive to repair degenerating 
muscle fibers (Blau et al., 1983). However, there are conflicting 
studies regarding the number and nature of muscle stem cells, 
and loss of satellite cells with age is questioned as there appear 
to be higher numbers of satellite cells in DMD muscle than 
there are in normal muscle (Watkins and Cullen, 1986, 1988; 
Maier and Bornemann, 1999; Kottlors and Kirschner, 2010). 
Reports of diminished DMD myoblast proliferation have been 
associated with low minimal telomere length in DMD whole 
muscle (Aguennouz et al., 2011) and myoblasts (Decary et al., 
2000). However, this remains controversial as another investi-
gation detected no overall reduction in mean telomere length in 
DMD muscle cells (Oexle et al., 1997).
An alternative hypothesis promoted for failed regenera-
tion is the excessive connective tissue proliferation (fibrosis), 
a feature in common with many chronic inflammatory states 
(Serrano et al., 2011). Fibrosis could impair vascularization of 
muscle tissue, create an insufficient environment for effective 
satellite cell proliferation and differentiation, and alter cell–cell 
communication during myofiber regeneration. Histologically, 
fibrosis is characterized by the exaggerated expression and 
deposition of extracellular matrix components, particularly 
collagen I. TGF-, a key cytokine promoting fibrosis, appears 
to have a critical role in fibrosis in DMD (Chen et al., 2005; 
MacDonald and Cohn, 2012) as well as most fibrotic states in 
most tissues (Akhurst and Hata, 2012; Bowen et al., 2013). 
Strong induction of TGF- pathways is seen in both successful 
and unsuccessful remodeling (Karkampouna et al., 2012). Indeed, 
TGF- is important for normal muscle regeneration, and the 
molecular mechanisms underlying a change in normal versus 
pathological roles of TGF- pathways have remained elusive 
for muscular dystrophy and other chronic inflammatory states 
(Bhattacharyya et al., 2013). The likely importance of TGF- 
pathways in DMD is underscored by the recent finding of two 
genetic modifiers of disease severity, both of which map to TGF- 
pathways (SPP1/osteopontin [Pegoraro et al., 2011; Bello et al., 
2012]; LTPB4 [Flanigan et al., 2013]).
Here, we used a data-driven approach involving three 
large mRNA profiling experiments (two human muscle biopsy 
and one murine regeneration series) to generate a novel hypoth-
esis regarding the cellular underpinnings of failed regeneration 
in muscle disease (asynchronous regeneration). The hypotheti-
cal model was then tested using an experimental approach of 
asynchronous bouts of staged degeneration/regeneration in 
localized microenvironments of wild-type (WT) muscle.
Results
Development of bioinformatics methods  
for increased sensitivity of biochemical 
network selection
It is well documented that different analytical methods applied 
to the same microarray dataset can provide very different inter-
pretations of the data, often with only 30% concordance of lists 
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greater failed remodeling, and regeneration), and DMD, JDM, 
and LMNA often (but not always) show more severe pathol-
ogy at the initial diagnosis compared with the other disorders in 
the dataset.
To test whether the network was more reflective of tissue 
pathology than clinical and molecular diagnosis, a second vali-
dation dataset was generated that was then analyzed by unsuper-
vised clustering. This new dataset contained 49 patient muscle 
biopsies analyzed on HG-U133 plus 2.0 microarrays. Samples 
studied were 6 normal volunteers, 17 DMD, 11 BMD, 7 LGMD2I 
(limb girdle muscular dystrophy type 2I; FKRP [fukutin-related 
protein deficiency]), and 8 LGMD2B.
Unsupervised clustering using the 56 network members 
from Fig. 1 resulted in clustering of the 49 biopsies into two 
distinct groups indicated by the dendrogram at the top (Fig. 1, 
purple left group with uniform down-regulation of transcripts 
and blue right group with uniform up-regulation; and Fig. 2). 
The two branches did not correspond well to clinical/molecular 
diagnosis, with Becker, Duchenne, FKRP-deficient and dysferlin-
deficient patients seen in both groups. To test whether the 
segregation of groups was caused by histopathology of the 
show particularly severe histological patterns of fibrosis and 
failed regeneration early in the disease process.
As shown in Fig. S1, this grouping was expanded to both 
A and B microarrays and both PLIER and dCHIP (DNA chip 
analyzer) probe set algorithms. Applying IPA (Ingenuity Pathway 
Analysis) to this clustering, we found the top-ranked networks 
to share many component members, and these were merged into 
a 56-member network (Fig. 1 B). Fold changes were displayed 
using both node size and intensity of color, with the numeric 
value shown under each node. Statistical support for differential 
regulation of component members is shown for the PLIER 
algorithm (Table 1).
This network was centered on TGF-, a well-studied 
cytokine associated with pathological fibrosis in many tissues 
(Akhurst and Hata, 2012; Bowen et al., 2013) and included 
many of the known components of fibrotic tissue (collagens and 
lysine oxygenases). Another notable component of the network 
was HIF1A (hypoxia-inducible factor 1,  subunit), a known 
transcription factor strongly induced by tissue ischemia (Koh 
and Powis, 2012). The nature of the network suggested that it 
was simply reflective of a more severe pathology (greater fibrosis, 
Figure 1. An iterative composite scoring bioinformatics approach identifies a transcript network associated with progressive muscular dystrophy.  
(A) Shown is a heat map of 117 muscle biopsies grouped by diagnostic category. The individual transcripts (y axis) defining this disease clustering were 
used to generate the molecular network in B. Disorders studied were facioscapulohumeral muscular dystrophy (FSH), normal human skeletal muscle (NHM), 
amyotrophic lateral sclerosis (ALS), acute quadriplegic myopathy (AQM), Becker muscular dystrophy (BMD), LGMD2A (CALP3), LGMD2B (DYSF), LGMD2I 
(FKRP), Emery–Dreifuss muscular dystrophy X-linked (EMRN [emerin]), Emery–Dreifuss muscular dystrophy autosomal dominant (ED-D; LMNA mutations), 
juvenile dermatomyositis (JDM), and Duchenne muscular dystrophy (DMD). (B) Shown is the integration of component mRNAs from the clustering in A into 
functional relationships based upon the literature (IPA). The top-ranked Ingenuity networks were merged into a 56-transcript network. This network is seen 
to be centered on TGF- and fibrosis (collagens and other extracellular matrix transcripts), and the network is visualized based on the typical subcellular 
localization of the encoded proteins of each transcript. Red symbols represent up-regulated transcripts, with the size of the symbol and intensity of color 
scaled to the observed fold change between groups (DMD, JDM, and ED-D vs. FSH, ALS, and NHM), with fold change with the PLIER algorithm provided 
under each symbol. Statistical data corresponding to this network are provided in Table 1.
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muscle studied, the archived interpretation of the severity of 
the dystrophy was accessed (all read by the same author, E.P. 
Hoffman; Fig. 2, normal, mild, moderate, or severe dystrophy 
groups). Mild was defined by evidence of degeneration and 
regeneration but little or no fibrosis or inflammation. Moderate 
showed increased inflammation and fiber size variation but 
minimal or moderate fibrosis. Severe showed fibrofatty replace-
ment of muscle and evidence of failed regeneration. Normal or 
mild pathology was seen in 20/22 patients in the left branch but 
only 3/27 in the right branch. In contrast, moderate or severe 
pathology was seen in 2/22 patients in the left branch and 24/27 
in the right branch. Thus, we concluded that this cluster and 
associated networks were more reflective of severity of histo-
logical pathology than clinical/molecular diagnosis.
Query of the putative failed regeneration 
network in normal staged tissue 
regeneration identifies  
time-resolved subnetworks
In many respects, the identification of the TGF-/fibrosis net-
work was quite expected, as fibrosis is associated with end-stage 
tissue pathology and with failed regeneration in many tissues, 
including muscle. However, the majority of patient muscle bi-
opsies were studied at initial diagnosis, before end-stage clini-
cal disease. Moreover, there is increasing evidence that TGF- 
is important for normal staged muscle regeneration (Philippou 
et al., 2008; Kollias and McDermott, 2008; MacDonald and 
Cohn, 2012). To query the relationship of this cluster with nor-
mal regeneration, we overlaid these network members over our 
previously published 27–time point murine in vivo muscle de-
generation/regeneration time series (Fig. 3; Zhao et al., 2003, 
2006; Zhao and Hoffman, 2004).
All network members for which we could identify cross-
species transcript units and probe sets did indeed show significant 
regulation of these transcripts in normal regeneration both by 
heat map (Fig. 3 A) and by statistical comparisons (Table 2). 
However, we noted from the heat map (Fig. 3 B) that different 
members of this pathology-associated network were expressed at 
different time points during normal regeneration. To visualize this 
temporal-specific pattern, we grouped the 27–time point murine 
series into four time frames corresponding to relatively distinct 
periods of muscle regeneration (myoblast proliferation—days 
1–3; myotube formation—days 3.5–4.5; myofiber maturation—
days 4.5–14; late-stage adaptation—days 20–40; Fig. 3 B). This 
parsed the TGF- network in Fig. 1 B into a series of time- 
resolved subnetworks shown in Fig. 3 B, where the relative ex-
pression levels were again coded by both symbol size and color 
intensity within each subnetwork. The extracellular matrix com-
ponents commonly associated with pathological fibrosis were 
seen in the myofiber maturation stage but not other stages.
This analysis evoked a novel hypothesis regarding the 
distinction between successful regeneration and unsuccessful 
remodeling (fibrosis). We reasoned that normal regeneration 
is synchronous, with specific pathways and pathway members 
having appropriate temporal expression patterns during the 
2–3-wk muscle regeneration process. In contrast, dystrophic 
Table 1. List of the 56 transcript genes in the TGF- network
Gene Probe set P-value Fold change
ACLY 210337_s_at 0.051 1.125
ASPN 219087_at <0.001 3.537
BGN 213905_x_at <0.001 3.717
BMP1 207595_s_at 0.165 1.089
BNIP3L 221478_at <0.001 1.406
CALD1 212077_at <0.001 1.767
CAP1 200625_s_at <0.001 2.218
CAV2 203324_s_at <0.001 1.76
CFL1 200021_at <0.001 1.695
CNN3 201445_at <0.001 2.274
COL1A1 202310_s_at <0.001 5.386
COL1A2 202404_s_at <0.001 4.89
COL3A1 211161_s_at <0.001 3.387
COL4A1 211981_at <0.001 2.469
COL4A2 211966_at <0.001 2.762
COL5A1 212489_at <0.001 2.58
COL5A2 221729_at <0.001 3.379
COL6A1 213428_s_at <0.001 2.045
COL6A2 209156_s_at <0.001 2.251
COL6A3 201438_at <0.001 2.131
COLEC12 221019_s_at <0.001 2.363
CSRP2 207030_s_at <0.001 1.524
CUGBP2 202158_s_at <0.001 1.537
CYB561 209163_at <0.001 1.27
DAB2 201280_s_at <0.001 2.385
ECGF1 204858_s_at <0.001 2.037
EMILIN1 204163_at <0.01 2.002
ENG 201809_s_at <0.001 1.441
HIF1A 200989_at <0.001 1.981
IFI30 201422_at <0.001 1.886
JAG1 209098_s_at <0.001 1.458
KDELR2 200699_at <0.001 1.361
LOX 215446_s_at <0.001 2.516
LOXL1 203570_at <0.001 2.013
LOXL2 202998_s_at <0.001 1.744
LTBP3 219922_s_at <0.001 1.507
PGCP 208454_s_at <0.01 1.237
PGRMC1 201121_s_at <0.001 1.495
PLOD2 202620_s_at <0.001 1.725
PLS3 201215_at <0.001 1.59
RASSF1 204346_s_at <0.05 1.163
RSU1 201980_s_at <0.001 1.522
S100A11 200660_at <0.001 2.888
SDC2 212158_at 0.269 1.132
SDC3 202898_at <0.001 2.136
SDCBP 200958_s_at <0.001 1.408
SERPINH1 207714_s_at <0.001 1.73
SPARC 200665_s_at <0.001 2.205
TAX1BP3 209154_at <0.001 1.64
TBCD 211052_s_at <0.001 1.581
TGFB1 203085_s_at <0.001 2.626
TGFBI 201506_at <0.001 1.852
TGFBR2 208944_at <0.001 1.852
TGFBR3 204731_at 0.065 1.213
TPM4 209344_at <0.001 2.086
TUBB2A 204141_at <0.001 2.16
List of the 56 transcript genes in the TGF- network (Fig. 1 A) and their fold changes 
and p-values of t test for testing the significance of their changes between two groups: 
up-regulated group (DMD, JDM, and ED-D) and down-regulated group (FSH, NHM, 
and ALS). The results shown were from the data processed with PLIER. Those few 
transcripts showing nonsignificant p-values here are included, as they met significance 
thresholds with dCHIP mismatch probe set algorithm (not depicted).
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low dose of notexin, using a red tattoo dye. Mice were sacri-
ficed 13 d after the second injection, a time point when regener-
ation should be largely complete for both areas. We then focused 
on specific areas of the muscle, where both injection sites were 
separated by a relatively small area (50–300 myofibers)—the 
hypothesis being that myofibers in the microenvironments im-
mediately at the injection sites would be synchronously regen-
erating, whereas the myofibers in between the two injection 
sites would receive regeneration cues from both sites (cross 
talk microenvironment).
In an initial experiment, injections were spaced by 0 
(two injections at the same time), 1, 2, 4, 5, and 10 d (four muscles 
at each time point). Cryosections from the belly of each muscle 
were analyzed for fibrotic content (Fig. S3 A). This analysis 
showed that increasing time between injections resulted in in-
creasing content of fibrosis of the muscle (Fig. S3 A). This sug-
gested that the timing of injections influenced the amount of 
fibrotic tissue deposited in the muscle as a whole tissue.
We hypothesized that asynchronous remodeling may re-
sult from interference in intercellular signaling when two nearby 
groups of myofibers are at different stages of regeneration. 
muscle was an asynchronous remodeling process, with dif-
ferent regions of the small muscle biopsy studied in different 
stages of regeneration.
This analysis established the hypothetical model in which 
asynchronous remodeling may be the driver for failed regenera-
tion, muscle wasting, and early death in the severe dystrophies. 
By this model, the complete TGF-–centered network shown in 
Fig. 1 is only possible in dystrophic muscle. In normal muscle, 
it is parsed into subnetworks resolved by time. We then sought 
to test this model experimentally.
Establishing a model of asynchronous 
muscle regeneration
We reasoned that a potential experimental model to test asyn-
chronous regeneration would be to induce localized regions of 
muscle degeneration/regeneration in WT mice, with repetitive 
regional injuries in close proximity within the muscle at defined 
time points. The experimental design is shown in Fig. S2. In 
brief, low doses of notexin (10 µl notexin at 5 mg/µl) were in-
jected intramuscularly along with a blue tattoo dye. At a defined 
time point later, a second injection was performed with the same 
Figure 2. Unsupervised (blinded) clustering of individual muscle biopsies from a 49-biopsy validation mRNA profiling dataset. Shown is a heat map using 
the same 56-member TGF- network from Fig. 1 B, with visualization of unsupervised clustering of individual biopsies. The specific mRNAs are on the 
y axis (not depicted), with individual patient biopsies on the x axis (diagnosis, patient number, [age at biopsy], and blinded classification of severity of the 
histology [normal, mild, moderate, and severe]). The heat map shows bimodal stratification of biopsies (two branches of dendrogram at the top), with the 
right branch clustering those biopsies with high levels of all or most of these transcripts, whereas the left branch shows lower levels of these transcripts. This 
clustering is seen to be driven by the severity of the pathology and not patient diagnosis or age (right branch, moderate or severe dystrophic pathology; 
left branch, normal or mild dystrophic pathology).
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Figure 3. The TGF- network superimposed on normal mouse muscle regeneration shows strong induction of subsets of the network at specific time frames 
during regeneration. The components of the human TGF- network (Fig. 1 B) were cross-mapped to the mouse genome and queried in a 27–time point 
muscle regeneration mRNA profiling dataset (Zhao et al., 2003). The top shows heat map visualization, with network members listed on the right y axis, 
and the time points after regeneration are shown on the x axis (days). Each member of the TGF- network shows up-regulation within certain stages of 
normal staged muscle regeneration, although these stages vary depending on the specific network member. The time points are shown grouped (colored 
boxes) into early myoblast proliferation stage (blue box), myotube stage (yellow box), myofiber maturation stage (purple box), and late myofiber adapta-
tion stage (red box). The transcripts showing up-regulation within each of these stages of regeneration were then used to generate networks (bottom). This 
shows that the TGF- network seen in muscular dystrophy muscle (Fig. 1 B) is parsed into subnetworks based upon the stage of normal regeneration that 
the subset of transcripts is expressed. Numbers indicate fold change. Statistical data associated with this network and heat map visualization are provided 
in Table 2.
145Asynchronous remodeling of muscle • Dadgar et al.
To test this, we used laser capture microscopy (LCM) to collect 
groups of myofibers at the sites of injury, as identified by red 
and blue tattoo dyes, and the myofibers in between the sites 
of injury. We focused on the mouse groups of 0, 4, and 10 d 
between injections.
Five regions were excised using LCM from each muscle: 
(1) blue dye area (injection 1; 17 d after injection for 4-d series 
and 23 d after injection for 10-d series), (2) red dye area (injec-
tion 2; 13 d after injection for both series), (3) muscle fibers in 
between the two injections sites (called in-between), (4) normal 
nonregenerating (intact) myofibers (identified by peripheral nu-
clei), and (5) single regeneration site (single dye area with no 
evidence of the second dye). These areas were identified by cen-
tralized nuclei myofibers located in the external area of one in-
jury site (either blue or red).
LCM-excised regions were used for mRNA isolation and 
mRNA profiling using Illumina bead arrays. Unsupervised chip 
clustering showed excellent signal/noise balance, as indicated by 
the clustering of microarray replicates of LCM from adjacent 
muscle sections (Fig. S2 C). For data analysis, we first compared 
region 4 (uninjured) versus region 5 (single regeneration). There 
were very few differentially regulated transcripts, suggesting that 
the muscle in region 5 had indeed successfully regenerated to 
completion. Likewise, there were few statistically significant dif-
ferences between region 1 (first injury) versus region 5 and region 
2 (second injury) versus region 5 (single site), consistent with 
successful remodeling (unpublished data).
In contrast, comparison of the tissue in-between injuries 
(area 3) showed mRNA expression profiles that were quite dis-
tinct from neighboring regions and also remarkably different for 
the 4-d series (Fig. 4) versus the 10-d multiinjury series (Fig. 5). 
Specifically, the 4-d in-between myofiber region showed a rela-
tive loss of mitochondrial-related transcripts and an increase in 
inflammatory transcripts (Fig. 4, left). The 10-d in-between myo-
fiber region showed increase of extracellular matrix components 
(Fig. 5, left). Statistical comparison of fold changes and p-values 
between the 4- and 10-d multiple injection sites showed highly 
significant differences, with the mitochondrial changes specific 
to the 4-d time series (Table 3) and the extracellular matrix tran-
scripts specific to the 10-d time series (Table 4). Alignment of the 
Table 2. The subset of genes of TGF- network significantly up- 
regulated in each of the four stages in the normal muscle regeneration 
process and the t test results
Gene Probe set P-value Fold change
0.5–1 d vs. 
control
Hif1a 98628_f_at <0.01 7.576
Hif1a 98629_f_at <0.01 7.666
Lox 160095_at <0.05 6.818
Rassf1 102379_at <0.01 3.911
S100a11 98600_at <0.05 9.611
1–3 d vs.  
control
Acly 160207_at <0.001 3.721
Bgn 162347_f_at <0.01 3.643
Bgn 96049_at <0.01 3.013
Cap1 93721_at <0.001 4.548
Cfl1 99119_at <0.001 10.262
Cnn3 160150_f_at <0.05 2.748
Dab2 104633_at <0.01 9.586
Dab2 98044_at <0.01 4.343
Dab2 98045_s_at <0.001 22.223
Eng 100134_at <0.001 3.961
Hif1a 98628_f_at <0.001 7.293
Hif1a 98629_f_at <0.001 7.546
Ifi30 97444_at <0.01 19.497
Lox 160095_at <0.01 9.566
Loxl1 103850_at <0.001 4.622
Rassf1 102379_at <0.01 3.11
S100a11 98600_at <0.001 10.499
Sdcbp 93017_at <0.001 13.648
Serpinh1 94817_at <0.01 3.182
Tgfb1 101918_at <0.01 9.295
Tgfbi 92877_at <0.001 13.304
Tpm4 95542_at <0.001 5.322
Tpm4 95543_at <0.001 5.865
Tubb2a 94835_f_at <0.01 7.055
4.5–14 d vs. 
control
Bgn 162347_f_at <0.001 6.38
Bgn 96049_at <0.01 4.61
Bmp1 92701_at <0.001 3.69
Cfl1 99119_at <0.001 4.415
Cnn3 160150_f_at <0.001 3.484
Col3a1 102990_at <0.001 13.005
Col5a1 101080_at <0.001 10.476
Col5a1 93472_at <0.001 4.456
Col5a2 92567_at <0.001 7.531
Col6a1 162459_f_at <0.001 3.744
Col6a1 95493_at <0.01 3.064
Col6a2 93517_at <0.001 4.097
Col6a3 101110_at <0.01 6.551
Csrp2 93550_at <0.001 6.048
Dab2 104633_at <0.001 3.517
Dab2 98045_s_at <0.001 5.182
Eng 100134_at <0.001 2.702
Hif1a 98628_f_at <0.001 3.57
Hif1a 98629_f_at <0.001 3.659
Ifi30 97444_at <0.001 9.03
Lox 160095_at <0.001 8.897
Loxl1 103850_at <0.001 5.968
Table 2. The subset of genes of TGF- network significantly up- 
regulated in each of the four stages in the normal muscle regeneration 
process and the t test results (Continued)
Gene Probe set P-value Fold change
S100a11 98600_at <0.001 4.693
Sdcbp 93017_at <0.001 5.552
Serpinh1 94817_at <0.05 3.431
Tgfb1 101918_at <0.01 4.799
Tgfbi 92877_at <0.001 3.619
Tpm4 95542_at <0.001 3.229
Tpm4 95543_at <0.001 4.181
Tubb2a 94835_f_at <0.001 4.807
20–40 d vs. 
control
Col5a1 101080_at <0.01 2.999
Loxl1 103850_at <0.01 2.592
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point in normal regeneration (Fig. 5, right). Statistical analysis 
showed that this pattern was largely specific to the 10-d staged 
remodeling and not seen in the 4-d staged remodeling (Table 4).
The microarray data from the 10-d interval injury model 
showed that the myofiber region in between asynchronous in-
juries showed inappropriate persistent expression of connective 
tissue-remodeling transcripts, and this would be consistent with 
the pathological findings of localized tissue fibrosis. Although 
we had previously shown an overall increase in fibrosis that was 
highest in the day 10 staged series muscle (Fig. 3 A), we refined 
this analysis to the localized area in between the two injection 
sites (Fig. 6). Histological visualization of the area between 
the two injection sites showed dramatic fibrotic replacement of 
muscle in the 10-d series, which was not seen with the 0- and 
4-d series (Fig. 6).
Targeted experiments confirm aberrant 
expression of fibrotic transcripts (10 d 
apart) and persistent inflammation and loss 
of mitochondrial capacity (4 d apart)
To validate the mRNA microarray findings, we selected specific 
transcripts and proteins to evaluate using an independent series 
of mice that had been subjected to the same 4- and 10-d asyn-
chronous muscle injuries. Tattoo dyes were used to visualize the 
Figure 4. Muscle tissue areas located between asynchronous injuries spaced 4 d apart show chronic inflammation and loss of mitochondrial transcripts. 
LCM was used to isolate regions of myofibers in between injury sites (cross talk area) spaced 4 d apart, with muscles studied 13 d after the second injection 
when myofiber regeneration was expected to be largely complete. Shown is the top-ranked Ingenuity network (left) reflective of chronic inflammation (red 
gene/protein symbols), and loss of mitochondrial components (green symbols). This network was then superimposed on normal murine regeneration time 
series (right), separated by the mitochondrial-related transcripts (down-regulated genes; top right) and inflammatory transcripts (up-regulated genes; bottom 
right). The mice that were sacrificed after regeneration should be largely complete (17 d postinjection [DPI]). However, the myofibers between the two injury 
sites showed expression patterns that were more consistent with the 4-d time point (4 d postinjection). Statistical analyses associated with the heat map are 
provided in Table 4. These data suggest that the myofibers in between the two injury sites are suspended in a time period of regeneration, defined by the 
days between the two sequential injuries (cross talk microenvironment). Numbers indicate p-value (top) and fold change (bottom).
subcellular localizations of the components of the top-ranked In-
genuity networks for the 4 and 10 d confirmed the preponderance 
of intracellular protein changes in the 4 d, in contrast to the extra-
cellular matrix components in the 10 d (Fig. S3, B and C).
We then overlaid the gene networks in Fig. 4 over nor-
mal staged muscle regeneration, separating the up-regulated 
and down-regulated transcripts (Fig. 4, right). This showed 
that the down-regulated mitochondrial transcripts were highly 
expressed in uninjured and fully regenerated muscle but were 
strongly down-regulated both in the 4-d in-between area as 
well as the 4-d time point during normal staged regeneration. 
This was consistent with the myofibers in between the two in-
jury sites having suspended regeneration at the 4-d time point. 
Similarly, the up-regulated inflammatory transcripts in the in-
between area separated by 4 d were highly expressed at the 4-d 
time point of normal staged regeneration but not at the later fully 
regenerated time point (Fig. 4). Thus, both the down-regulated 
mitochondrial transcripts and the up-regulated inflammatory 
transcripts in the in-between area appeared arrested at the time 
point separating the asynchronous injury times.
The 10-d staged injury series was also consistent with the 
suspended development model. Connective tissue remodeling 
transcripts were highly up-regulated in the in-between area sepa-
rated by 10 d, and this pattern was consistent with the 10-d time 
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Figure 5. Muscle tissue areas located between asynchronous injuries spaced 10 d apart show a high level expression of profibrotic gene networks. Shown 
is data for the LCM region of muscle between the two injury sites spaced 10 d apart. The myofibers between the two injury sites show a high level expres-
sion of transcripts associated with connective tissue proliferation and fibrosis (top-ranked Ingenuity network, left). Superimposing this network on normal 
staged murine regeneration shows that the myofibers in the area between the two injury sites show expression patterns consistent with suspension in the 
10-d time point of normal regeneration. Statistical analyses associated with the heat map are provided in Table 4. Numbers indicate p-value (top) and 
fold change (bottom). DPI, day postinjection.
Table 3. Down-regulated metabolic gene transcripts are shared between 3 and 4 d of synchronous regeneration and 4-d  
asynchronous remodeling
Genes P-value/FC
27–time point single regeneration series Double injection LCM series
4 d between injections 10 d between injections
3/4 da 9/10 da 13/14 da 30/40 da Single siteb In-betweenb Single siteb In-betweenb
ATP5A1  
100753_at
0.06 NS NS NS NS 0.004/3.27 NS NS
COX6B1 
99114_r_at
0.01 NS NS NS NS 0.002/3.62 NS NS
CYCS  
98132_at
0.06 NS NS NS NS 0.0002/12 NS NS
NDUFB5 
97307_f_at
0.002 0.05 0.05 0.04 NS 0.001/4.6 NS 0.002/2.5
UQCRC1 
101989_at
0.07 NS NS NS NS 0.009/2.6 NS NS
ART1  
104638_at
0.02 NS NS NS NS 0.00009/2.4 NS NS
ARL1  
97505_at
0.02 NS NS NS NS 0.0005/3.5 NS NS
MRPS12 
98547_at
0.02 NS NS 0.04 NS 0.0006/5.4 NS NS
MRLP20 
94875_at
0.01 NS NS NS NS 0.006/3.6 NS NS
The nine mRNA transcripts shown were significantly down-regulated in the region between asynchronous injection sites in the double LCM series when injections were 
separated by 4 d, but not 10 d (8/9). In a separate 27–time point synchronous regeneration time series, these same transcripts were down-regulated at the 3–4-d 
time point and not later time points. FC, fold change.
aDays are versus 0.
bSites are versus nonregenerating.
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10 d apart; CD11b, CD74, and CD163; Fig. 7). These proteins 
were selected based on their role in proinflammatory pathways 
as well as DMD pathogenesis. CD11b is a leukocyte marker 
that induces innate immune response resulting in phagocytosis 
and cell-mediated cytotoxicity (Solovjov et al., 2005). CD11b 
immunostains showed the highest expression in the in-between 
region at 4 d but not 10 d or the simultaneous injection con-
trol (Fig. 7 A).
Human leukocyte antigen class II histocompatibility an-
tigen  chain (CD74) was selected because of its role in regulat-
ing adaptive immune response upon injury and its induction of 
NFK- pathways (one of the earliest proinflammatory markers 
of DMD; Cresswell, 1994; Chen et al., 2005). CD74 showed 
mRNA up-regulation in the 4-d between area and not the 10-d 
area (Fig. 4 and Table 3). Immunostaining of CD74 showed ex-
pression in the region between the 4-d injection sites but not the 
region in between the 10-d injection sites (Fig. 7 B). CD74 was 
also not seen in the injection sites themselves.
CD163 is a marker of specific macrophage subtypes (M2c) 
in dystrophin-deficient muscles, is associated with increased 
tissue repair (Villalta et al., 2009), and is a known acute phase-
regulated receptor (Madsen et al., 2001). The immunostaining 
first and second injection sites. Tissue for quantitative RT-PCR 
(qRT-PCR) was obtained by LCM. Immunohistochemistry and 
enzyme histochemistry were also performed.
The 4-d interval injury model showed an increase in 
inflammatory transcripts and a relative loss of mitochondrial-
associated transcripts (Fig. 4). qRT-PCR confirmed the mRNA 
profiling data, showing preferential loss of mitochondrial tran-
scripts in the region in between the two injections sites, relative 
to other regions of the same muscle tissue and the area between 
two notexin injections made on the same day (Table 5). To 
confirm the relative loss of mitochondrial oxidative capacity 
predicted by expression microarray and qRT-PCR microarray 
data for the 4-d in-between areas, we used standard enzyme his-
tochemistry (NADH, cytochrome c oxidase [COX], succinate 
dehydrogenase [SDH], and a combination of NADH and COX 
enzymatic staining). The region between the 4-d interval injec-
tion sites showed a relative loss of mitochondrial enzymatic 
activity stains compared with other injection paradigms, con-
firming the microarray data (Fig. S4).
To validate the up-regulation of proinflammatory tran-
scripts, we studied three proteins by immunofluorescence lo-
calizations in three double injury mice (injuries spaced 0, 4, and 
Table 4. Up-regulated fibrosis-associated gene transcripts are shared between 9 and 14 d of synchronous regeneration and 10-d asynchro-
nous remodeling
Genes P-value/FC
27–time point single regeneration series Double injection LCM series
4 d between injections 10 d between injections
3/4 da 9/10 da 13/14 da 30/40 da Single siteb In-betweenb Single siteb In-betweenb
ACTA2 
93100_at
0.001 0.006 0.002 NS NS 0.005/8.3 NS 0.008/16.8
COL6A1 
95493_at
0.003 0.0001 0.0001 0.02 NS 0.002/3.6 NS 0.00004/7.2
COL18A1  
101039_at
0.00001 0.0003 0.01 NS NS NS NS 0.0001/4.0
COL4A2  
101039_at
NS 0.01 0.008 NS NS NS NS 0.0007/4.5
ELN  
92207_at
NS 0.004 0.02 NS NS NS NS 0.00004/3.2
MMP14  
160118_at
0.0007 0.0002 0.006 NS NS NS NS 0.0006/10.6
COL14A1  
99476_at
0.007 0.004 0.002 NS NS NS NS 0.0003/1.5
COL15A1 
99637_at
0.02 NS 0.006 NS NS NS NS 0.004/1.6
C2  
103673_at
0.02 0.02 NS NS NS NS NS 0.000009/2.6
STAT3 
99099_at
0.02 0.002 0.05 NS NS NS NS 0.003/4.4
CDKNA1 
94881_at
0.03 0.05 0.009 NS NS NS NS 0.00007/3.25
RAMP2 
994444_at
NS 0.007 0.006 NS NS NS NS 0.0007/3.5
ACVR2B 
994444_at
NS 0.007 0.006 NS NS NS NS 0.0004/6.45
The 13 gene transcripts shown were significantly up-regulated in the region between asynchronous injection sites in the double LCM series when injections were sepa-
rated by 10 d, but not 4 d (0/13). In the 27–time point synchronous regeneration time series, these same transcripts showed the highest and consistent up-regulated 
between 9 and14 d. FC, fold change.
aDays are versus 0.
bSites are versus nonregenerating.
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mRNA profiling. Histochemical staining for mitochondrial 
enzyme function showed the variable loss of mitochondrial oxi-
dative phosphorylation activity typically seen in DMD biopsies 
(Fig. 9 B). There were variable degrees of inflammation and 
fibrosis, as detected by Masson’s trichrome and Gomori’s tri-
chrome (Fig. 9, C and D). Unsupervised clustering of the mi-
croarrays from adjacent sections showed clear and consistent 
differences in expression profiles from the six regions, with rep-
licates of profiles clustering together, yet each region showing 
a distinct pattern from other regions.
As we were unable to specifically stage the pathology of 
the human biopsy, the specific timing of the degeneration and 
regeneration cycles of the six regions could not be determined. 
Nonetheless, the profiles were consistent with asynchronous 
bouts of degeneration/regeneration leading to chronic inflam-
mation and mitochondrial function loss associated with the mu-
rine 4-d spaced multiple injuries and the fibrosis associated with 
the 10-d multiple injuries.
Pharmacogenomics of glucocorticoids  
on the proposed intercellular  
signaling networks
Daily glucocorticoids are considered standard of care in DMD 
(Bushby et al., 2010). The mechanisms of action of glucocorticoids 
in DMD are thought to be through antiinflammatory mechanisms 
as in other chronic inflammatory states (Hoffman et al., 2012). 
patterns for CD163, cell surface markers of monocytes and macro-
phages class II (M2c), showed similar patterns (Fig. 7 C).
For the 10-d interval injuries, we had shown increases in 
connective tissue by histological methods (Fig. 6 and Fig. S3 A). 
To further validate this finding by immunostaining of specific 
proteins, CD206 (MRC1 [mannose receptor, C type 1]; macro-
phage marker) and MMP9 (metalloproteinase implicated in 
dystrophy pathogenesis; Dahiya et al., 2011a,b; Miyazaki et al., 
2011) were studied (Fig. 8). Both showed strong expression of 
the myofiber in-between region of injuries spaced 10 d apart, 
with lack of immunostaining in 4-d injuries or 0-d control.
LCM of human DMD patient muscle  
shows patterns consistent with 
asynchronous remodeling
Muscle biopsies from DMD patients have long been recognized 
to show grouped degeneration and regeneration and focal fibro-
sis. This histological pattern is consistent with the asynchro-
nous remodeling shown in our murine experimental model. To 
provide evidence for asynchronous remodeling in human DMD 
muscle at the molecular level, we studied a frozen diagnostic 
muscle biopsy from a young child with DMD (3 yr). Frozen 
sections were stained by hematoxylin and eosin to identify 
neighboring regions of myofibers both within fascicles and be-
tween fascicles (Fig. 9 A), and different subregions (1–6) were 
identified and then isolated by LCM and subjected to Illumina 
Figure 6. Histological analysis of connective tissue proliferation (fibrosis). Shown is Masson’s modified trichrome staining of cryosections in the area of 
muscle between injection sites staged 0, 4, and 10 d apart (n = 3 muscles per group). Endomysial fibrosis is most evident in the area between injections 
space 10 d apart, consistent with the LCM expression profiling data (Fig. 4 B).
Table 5. RT-PCR validation of loss of mitochondrial transcripts in the area between staged degeneration/regeneration cycles 4 d apart
Genes P-value/FC
Between 4D vs. single injury area Between 4D vs. intact/uninjured area  
(same section)
Between 4D vs. between area of the control 
synchronous mice
Cox6b1 0.0005/2.6 0.0004/4.9 0.004/1.4
Ndufs6 0.003/3.6 0.04/16.0 0.001/6.9
Ndufb5 0.01/4.9 0.002/11.0 0.02/11.0
Ndufb6 0.004/6.5 0.009/7.2 0.0002/20.0
FC, fold change.
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Recently, we developed a novel dissociative steroid, VBP15, 
that is similarly antiinflammatory yet lacks most side effects as-
sociated with glucocorticoid response element–mediated trans-
activation subactivities (Heier et al., 2013). We hypothesized 
However, extensive side effect profiles, such as muscle wasting 
typically associated with glucocorticoids, and differences in 
response between human and mouse models have complicated 
dissection of the molecular mechanism of action (Sali et al., 2012). 
Figure 7. Immunostaining of inflammatory 
proteins CD11b, CD74, and CD163 shows 
expression specific to intervening areas of 
muscle between injuries spaced 4 d apart. 
(A–C) Shown are immunofluorescence stains 
for inflammatory protein markers CD11b (A), 
CD74 (B), and CD163 (C). Each panel shows 
matched phase contrast (marking injury sites 
with tattoo dyes), antigen with nuclear stains 
(DAPI), and antigen alone. All three inflam-
matory markers show preferential localization 
in the area between the two injury sites only 
when injuries are spaced 4 d apart and not 
0 or 10 d apart (n = 3 muscles per group). 
Arrows indicate immunoreactive material in the 
microenvironment between two neighboring 
sites of regeneration.
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We tested the effects of drug treatment on the TGF-–
based asynchronous remodeling networks both in the mdx mouse 
model as well as the WT asynchronous remodeling experimental 
system. For the mdx model, we obtained frozen muscle samples 
from a previously described preclinical trial of prednisone and 
that both prednisone and VBP15 might serve to suppress inap-
propriate intercellular signaling in the regions between asyn-
chronously injured and remodeling areas of muscle, particularly 
those associated with the proinflammatory 4-d asynchronous 
cross talk regions.
Figure 8. Immunostaining of proteins profibrotic markers MMP9 and CD206 shows preferential expression the area of muscle between injuries spaced 
10 d apart. (A and B) Two markers associated with fibrosis, MMP9 (A) and CD206 (B), are shown by immunostaining in muscles from repeated injuries 
(control = 0 d apart; 4 and 10 d apart). Both markers show preferential expression in the area in between the two injury sites when the injuries are spaced 
10 d apart and not 0 (control) or 4 d (n = 3 muscle per group). Arrows indicate immunoreactive material in the microenvironment between two neighbor-
ing sites of regeneration.
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VBP15 (Heier et al., 2013). Drug treatments were started at 
10 wk of age and continued to 26 wk of age (4 mo of treatment). 
Skeletal muscles (gastrocnemius) of mice treated with 5 mg/kg/d 
prednisone and 15 mg/kg/d VBP15 were tested by mRNA profil-
ing (n = 5 per group) using Illumina bead arrays. As a baseline 
study, the human TGF-–centered network, including HIF1A and 
S100A11 nodes, was queried in untreated mdx versus WT mice, 
and this showed strong up-regulation of the majority of network 
members (22/29; Fig. 10 A). A marked exception was HIF1A, 
a key ischemia-responsive gene; however, the rapid expression 
of HIF1A upon necropsy may lead to postmortem expression in 
WT animals. Comparing prednisone- and VBP15-treated mdx 
Figure 9. LCM of regions of a muscle biopsy from a DMD patient. (A–D) A frozen muscle biopsy from a 3-yr-old DMD patient was stained for hematoxylin 
and eosin (A), mitochondrial enzyme activity (SDH; B), Masson’s modified trichrome (C), and Gomori’s modified trichrome (D). Variable states of degen-
eration and regeneration can be seen within each fascicle. The different regions indicated (1–6) were isolated by LCM, and individual regions (n ≥ 3 per 
region) were analyzed by mRNA profiling. The areas were chosen based on visual histopathology, where both fascicles and relatively distinct histological 
subareas within the fascicles were chosen. Microarray data from replicates of LCM regions microdissected from adjacent cryosections was subjected to 
unsupervised chip-based clustering. This showed replicates to cluster closely in the dendrogram. This represents heterogeneity within fascicles in DMD 
muscle, as hypothesized by the asynchronous regeneration model described in the accompanying text.
mice with untreated mdx mice showed both drugs to significantly 
down-regulate the majority of the pathway members (15/29 pred-
nisone and 12/29 VBP15), including TGF- ligand and HIF1A. 
These data suggest that a possible mechanism of action of both 
prednisone and VBP15 is through suppression of the TGF-– 
related networks, leading to more successful regeneration.
We then used the same data analysis methods for the WT 
asynchronous remodeling experimental system, similarly deter-
mining the effect of drug treatment on expression of the TGF-  
network. As a baseline, expression profiles of LCM samples (cross 
talk area vs. single injury sites) was performed for both 4- and 
10-d asynchronous remodeling samples, with both showing 
153Asynchronous remodeling of muscle • Dadgar et al.
immunopositivity for these antigens (Fig. S5). These data 
are consistent with both glucocorticoids and VBP15 serving 
to inhibit inappropriate cross talk in asynchronously remodel-
ing muscle.
Discussion
We used a large-scale data integration approach to query the 
molecular underpinnings of progressive failure of regeneration 
in the muscular dystrophies (Fig. S1). Using an initial mRNA 
profiling dataset of 12 disease groups (117 biopsies and 234 
microarrays), we developed an iterative composite approach to 
identify clusters of transcripts that were associated with the more 
severe muscle disease classes (DMD, JMD, and LMNA; Fig. 1). 
Functional clustering of the diagnostic transcripts showed a 56-
member TGF-–centered network consistent with tissue fibro-
sis. Unsupervised clustering of an independent mRNA profiling 
dataset of 49 biopsies from four muscle disease groups (DMD, 
BMD, LGMD2I, and LGMD2B) and controls showed a strong 
correlation of the TGF-–centered network with pathological 
up-regulation of the TGF- network in the cross talk micro-
environment (10/29 for 4 d and 16/29 for 10 d; Fig. 10). The 
10-d cross talk microenvironment showed more extensive up-
regulation of the TGF- networks compared with 4 d, consis-
tent with the findings presented earlier (Fig. 5). Drug treatment 
of the WT 4-d asynchronous mouse model was performed 1 d 
before first injury and then continuously during the 13 d after 
recovery from the second injection (17 d total), using either 
5 mg/kg/d prednisone or 15 mg/kg/d VBP15. LCM and mRNA 
profiling of the cross talk microenvironment was compared 
with single injury microenvironment in the same muscle. This 
showed significant down-regulation by prednisone of TGF- 
network members in the cross talk region (Fig. 10).
To validate these findings at the immunohistochemical 
(protein) level, the WT 4-d asynchronous model drug-treated 
muscles were immunostained for CD11b, CD74, and CD163 
and compared with untreated mice. This analysis showed the 
expected high expression of each protein marker in the 4-d 
multiple injury sites (Fig. S5). However, daily administra-
tion of either prednisolone or VBP15 markedly reduced the 
Figure 10. Treatment with prednisone or VBP15 suppresses the TGF- network in both WT asynchronous remodeling and mdx mice. Top images are 
mRNA profile data of skeletal muscles from a 4-mo preclinical drug trial of 5 mg/kg/d prednisone and 15 mg/kg/d VBP15. Muscle functional testing and 
histology on this trial has been previously published (Heier et al., 2013). The TGF- and fibrosis pathways seen in experimental asynchronous remodeling 
and DMD biopsies were queried for the relative expression of mRNAs between the indicated samples, with red color indicating up-regulation (p-values 
underneath network members) and green color indicating down-regulation. Untreated mdx muscle shows strong up-regulation of the network (mdx vs. WT). 
Treatment with either prednisone (prednisone-treated mdx vs. untreated mdx) or VBP15 (VBP15-treated mdx vs. untreated mdx) shows strong suppression 
of this network. Bottom images show comparison of expression profiles from LCM samples of asynchronously remodeling regions of WT muscle. The cross 
talk region between injection sites shows up-regulation of the TGF- fibrosis network (higher in 10 d compared with 4 d) and prednisone treatment of 4-d 
asynchronous remodeling mice with prednisone suppresses the network (pretreated, 4-d cross talk area vs. uninjured).
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Our data showed that normal regeneration and failed re-
generation involve the same networks, differences largely being 
caused by the synchrony (episodic) nature of normal regenera-
tion and the asynchronous (repeated injury) nature of failed re-
generation. With failed regeneration, regenerating myofibers 
are likely receiving incorrect temporal cues from their neigh-
bors, and this inappropriate cross talk leads to inability to prog-
ress through the normal temporal stages of regeneration.
Glucocorticoids are derivatives of cortisol, the diurnal 
hormone that sets day/night cycles in most animals and plants. 
Pharmacological doses of glucocorticoids, typically given on a 
daily basis, are considered antiinflammatory and remain among 
the most effective drugs for chronic inflammatory states since 
their initial use in the 1940s. There is increasing recognition of 
the role of cortisol and clock genes in establishing cell cycle 
regulation throughout the body and that disturbances or blunt-
ing of diurnal cortisol fluctuations are associated with the proin-
flammatory state (Niimi et al., 2007; Holderfield and Hughes, 
2008). We recently showed that primary bronchial epithelial 
cells from asthmatic patients are intrinsically dyssynchronous, 
are proinflammatory, and poorly repair wounds, yet this can be 
normalized with pulsed glucocorticoids (Freishtat et al., 2011; 
Alcala et al., 2014).
We reasoned that the effectiveness of glucocorticoids in 
DMD may be caused by resynchronization of remodeling, thereby 
rescuing the inappropriate cross talk described in this paper. To 
test this, we treated WT mice with prednisolone, VBP15 (a disso-
ciative steroid), and vehicle/placebo and then tested for the drug 
regimens to rescue the inappropriate cross talk in our asynchro-
nous regeneration model. Drug treatments of both mdx mice and 
the WT asynchronous model were tested (Fig. 10 and Fig. S5). 
As hypothesized, both prednisolone and VBP15 reduced evi-
dence of cross talk in both mdx and the WT asynchronous mod-
els. These data suggest that part of the mechanism of action of 
both prednisone and VBP15 is through suppression of TGF- 
networks induced by asynchronous remodeling.
There is an extensive literature supporting many of the find-
ings in our study, although we believe that this study is the first 
to synthesize these observations into a single model. Specifically, 
transient TGF- activity is essential for maintaining normal 
tissue repair and regeneration, whereas persistent TGF- activity 
results in excessive fibrosis and, ultimately, scarring in skin and 
internal organs. In dystrophic muscle, TGF- may affect tissue 
fibrosis by elevating collagen secretion by fibroblasts and con-
verting myoblasts to fibroblasts. Furthermore, TGF- can inhibit 
terminal myogenic differentiation and thus impair muscle repair 
process (Alexakis et al., 2007).
Our model may provide an explanation for the enigmatic 
pathology of the mdx mouse. Dystrophin-deficient mouse muscle 
shows normal histology in early weeks postpartum (0–3 wk) and 
then a stage of widespread necrosis followed by relatively suc-
cessful regeneration. The mdx muscle in the range of 2–12 mo 
shows a mild dystrophy relative to human DMD muscle. Our 
model suggests that the widespread necrotic phase (2–3 wk) 
leads to well-synchronized regeneration; the severity of the initial 
necrotic phase may be beneficial in that it may avoid the poorly 
severity rather than diagnostic criteria (Fig. 2). However, all 
members of this same 56-gene TGF-–centered network were 
expressed during specific stages of normal muscle regenera-
tion, using a 27–time point staged murine regeneration dataset 
(Fig. 3 A). These data analyses established the hypothesis that 
normal regeneration and progressive dystrophy involved the 
same proteins; the only distinction was one of timing and degree 
of expression. The TGF- network was parsed into stage-specific 
subnetworks in normal muscle regeneration yet occurred within 
the same muscle at the same time in severely dystrophic muscle 
(Fig. 3 B). We hypothesized that asynchronous bouts of degen-
eration and regeneration in neighboring regions of muscle tissue 
could result in inappropriate cross talk between the regions.
To test this hypothesis, we developed an experimental 
model for asynchronous regeneration of muscle in neighbor-
ing microenvironments. An initial injury was induced in nor-
mal mouse muscle using notexin with the injection site labeled 
with tattoo dye. A second adjacent injection, labeled with a 
second tattoo dye, was subsequently made, at defined times 
(0–10 d). The mice were sacrificed 13 d after the second injec-
tion when regeneration would be expected to be largely complete 
(Fig. S2). Then, regions of the muscle containing both injec-
tion sites and regenerating myofibers in between the sites (cross 
talk microenvironment) were studied by LCM and in situ im-
munostaining methods. We found that increasing the time be-
tween injections led to a greater degree of abnormal collagen 
deposition (fibrosis; Fig. S3), indicating that the time period be-
tween injections was an important determinant of the response 
of the muscle to the damage. To better define the response of 
specific subregions of asynchronously remodeling muscle, we 
used LCM and mRNA profiling as well as immunostaining, 
histology, and enzyme chemistry experiments. Myofibers in 
between the two injury sites showed an expression pattern that 
seemed suspended within the developmental stage that sepa-
rated the two injections, with the 4- versus 10-d between staged 
injections sharing little similarity with each other (Fig. 4 and 
Fig. S3, B and C). The myofibers between the sites of the 10-d 
repeat injections showed strong expression of transcripts asso-
ciated with a profibrotic state, with high expression of colla-
gens, and other connective tissue remodeling networks (Fig. 5). 
This showed considerable overlap of network members, such as 
TGF-, COL1A1, COL4A1, COL4A2, and COL6A1, with the 
human muscle biopsy TGF- network associated with fibrosis 
(Fig. 1 B) and was similar to the myotube maturation subgroup 
of normal staged (synchronous) muscle regeneration (Fig. 3). 
To assign statistical support to these visualizations of LCM data 
networks, we took specific network members (mRNAs) and de-
fined expression changes (p-values and fold changes) in specific 
time points of regeneration, 4-d in-between LCM data and 10-d 
in-between LCM data (Table 4). The expression patterns were 
consistent with inappropriately prolonged and extensive con-
nective tissue remodeling, in which signaling led to suspension 
of progression through the 10-d time window of normal regen-
eration. In other words, the tissue region between the injection 
sites staged 10 d apart remained fixed in the 9–10-d regenera-
tion program and appeared unable to successfully mature past 
this developmental time point.
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algorithms that provide probe set normalization, chip normalization, and 
project normalization so that quantitative signals can be assigned to each 
probe set (transcript) represented on the microarray. We and others have 
shown that different probe set algorithms often lead to very different interpre-
tations of the same microarray image files (Seo et al., 2004, 2006; Seo and 
Hoffman, 2006). To avoid loss of sensitivity for gene selection by using a 
single probe set algorithm, we simultaneously interpreted the muscle biopsy 
data using three distinct probe set algorithms (dCHIP, MAS 5.0, and PLIER; 
Fig. S1). Both A and B microarrays were used, leading to two images with 
distinct probe sets representing each sample.
Two-way clustering on the rows (genes) and columns (muscular dis-
orders) of the data matrix was performed using the VISDA (Visual Statisti-
cal Data Analyzer) software to cluster genes (Fig. S1; Wang et al., 2000, 
2007; Zhu et al., 2008). Within each gene cluster, the clustering of the 
muscular disorders was performed using hierarchical clustering with corre-
lation as the similarity measure after a preprocessing step in which all sam-
ples within one muscle group were taken as an average.
This led to a series of probe set algorithm-specific gene clusters that 
grouped the muscular dystrophies into larger groups based upon the spe-
cific microarray used (U133A chip or U133B chip). Thus, PA cluster i refers 
to PLIER algorithm U133A chip dataset, MA cluster i refers to MAS 5.0 
algorithm U133A chip dataset, and dA cluster i refers to dCHIP algorithm 
U133A chip dataset (Fig. S1 and formulas in this section). Each gene clus-
ter was then tested for gene–gene and gene–protein interactions between 
cluster members using IPA. The top-ranked networks were then retained for 
each cluster i (PA network i, MA network i, and dA network i; Fig. S1). We 
then merged networks and assigned cumulative scores. To accomplish this, 
we implemented programs to query overlaps among networks and then 
derived a total score for each network based on its overlaps with all other 
networks of each gene-disorder pattern. The probability for two networks, 
S1 and S2 with n1 and n2 genes, respectively, having m overlapped genes 
can be calculated as
	 p m C C C
C C
N
m
N m
n m
N m
n m
N
n
N
n( ) = −
−
−
−1 2
1 2
, with 	
	 p mm
n n ( ) == ( )∑ 10 1 2
min , , 	
given that S1, S2, and the overlapped genes belong to the global net-
work with N genes (N = 26,400, the total number of mammalian genes 
in Ingenuity Pathway Knowledge base), and C represents a mathemati-
cal operation of combination. C of N and m gives the number of subsets 
of m distinct elements of a set of N elements. Because this probability 
indicates the likelihood of the overlap of the two networks occurring 
randomly, log10(p(m)) may be used as a score for specifying the reli-
ability of the overlap. In addition, the IPA dynamically computes rele-
vant networks by focusing on the genes of interest and delivers a set of 
scored networks for each gene cluster. A composite score for each net-
work was then calculated by summing up the IPA score and the total 
score based on network overlaps; the networks were ranked based on 
their composite scores.
Cross-species query of time series data
Once a gene cluster of interest was selected, probe sets were tested 
for recognition of canonical transcripts (e.g., 3 end of well-documented 
transcript units), and then, these human transcript units were mapped to 
corresponding rat and mouse transcript units using Affymetrix NetAffx 
Analysis Center. The Affymetrix probe set IDs corresponding to the tran-
script units were then queried against the mouse time series data. All 
mouse image files were analyzed using the PLIER probe set algorithm. 
Candidate gene clusters were visualized in mouse datasets using heat 
maps (hierarchical clustering).
All differentially regulated transcripts visualized were tested for sta-
tistical significance using t test, without correction for multiple testing. For 
time series data, adjacent time points were grouped and statistically com-
pared with a relevant control region of the time series.
Asynchronous regeneration protocol
WT BL57 mice of 4–8 wk of age were used for all asynchronous remodeling 
experiments. To induce asynchronous bouts of regeneration, a 20-guage 
needle was filled with 10 µl of 5-µg/ml notexin and then dipped in tattoo 
dye (blue for first injection; red for second injection). Both gastrocnemii were 
synchronized regeneration and pathology-associated signaling 
cross talk that occurs in human DMD muscle.
The regenerative asynchrony model may be applicable 
to chronic pathologies in nonmuscle tissues. Asthma involves 
chronic inflammation of the airway, where pulsed glucocorti-
coids are standard of care. In other studies, we have shown that 
normal epithelial wound repair is synchronous, that remodeling 
of asthmatic cells is asynchronous and proinflammatory, and 
that pulsed glucocorticoids restores regenerative synchrony and 
the nonproinflammatory state (Freishtat et al., 2011; Alcala et al., 
2014). One could extend these models to chronic liver pathol-
ogy, poor skin wound healing, or possibly all chronic inflamma-
tory tissue states leading to fibrosis.
Materials and methods
Human patient muscle samples and mRNA profiles
Flash-frozen neuromuscular disease patient muscle biopsies were taken for 
diagnostic purposes. Normal control biopsies were obtained from baseline 
samples from exercise experiments in young adult volunteers.
Two datasets were analyzed. The first (test set) has been previously 
published (Bakay et al., 2006). This set contained Affymetrix mRNA profiles 
from 117 patient muscle biopsies using both HG-U133A and HG-U133B 
microarrays (n = 234 microarrays total; GEO accession no. GSE3307). 
The muscle disease groups were DMD (n = 10), amyotrophic lateral scle-
rosis (ALS; n = 9), acute quadriplegic myopathy (n = 5), BMD (n = 5), CAL 
(calpain III gene mutations; LGMD2A; n = 10), DYSF (LGMD2B; n = 10), 
ED-R (Emery–Dreifuss muscular dystrophy X linked; n = 4), ED-D (n = 4), 
FKRP (LGMD2I; n = 7), facioscapulohumeral dystrophy (FSH; n = 14), JDM 
(n = 21), and normal human skeletal muscle (NHM; n = 18). Biopsies were 
taken generally at the time of diagnosis and were typically from the vastus 
lateralis. The original published dataset analyzed 13 groups, but we re-
moved the hereditary spastic paraplegia group from analyses reported here 
because of a high proportion of outlier transcripts and also removed four 
JDM samples that were not made public. To generate the mRNA profiles, 
frozen muscle biopsies were solubilized, total RNA was isolated, RNA was 
converted into biotinylated cRNA probes, hybridized to Affymetrix micro-
arrays, and detected using fluorescent streptavidin, and microarrays were 
scanned. Quality control metrics used were as previously reported (Tumor 
Analysis Best Practices Working Group, 2004).
A second set of 49 human patient mRNA profiles was generated 
using HG-U133 Plus 2.0 microarrays, and this dataset is new to this study. 
These datasets contained profiles from 6 normal controls, 17 DMD (absence 
of dystrophin), 11 BMD (present but abnormal dystrophin), 7 LGMD2I 
(FKRP deficiency, a glycosylation defect), and 8 LGMD2B (DYSF). Patients 
had a broad range of ages, clinical severity of their disease, and histo-
pathological findings, although all neuromuscular disease patients showed 
evidence of a dystrophic process (degeneration/regeneration of muscle 
fibers). Hematoxylin and eosin stains were performed on frozen sections, 
and the amount of fibrotic replacement (fibrosis) visually approximated for 
by the same evaluator (E.P. Hoffman) into normal, mild, moderate, or se-
vere fibrosis categories.
Murine muscle regeneration time series
Staged degeneration/regeneration of adult WT mice was induced by in-
tramuscular injection of cardiotoxin into the entire gastrocnemius muscle 
using a 10-needle manifold (Zhao and Hoffman, 2004). Mice were sacri-
ficed at 27 time points after the injection, and muscles showing homoge-
nous regeneration were selected for mRNA profiling (n = 2 per time point). 
Frozen muscle samples were solubilized, total RNA was isolated, RNA was 
converted to biotinylated cRNA, cRNAs were hybridized to MG-U74Av2 
microarrays, and fluorescent images were scanned (GEO accession no. 
GSE469). Analyses and validations of this degeneration/regeneration 
time series have been previously published (Zhao et al., 2003, 2006; 
Zhao and Hoffman, 2004).
Biostatistical clustering methods
We developed a novel method of defining gene clusters within a large multi-
group dataset, using the 12-group human muscle biopsy dataset (Fig. S1). 
Mapped image files from microarrays are interpreted using probe set 
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mouse monoclonal antibodies on mouse tissue sections (n = 3 muscles per 
group). Goat anti–mouse (Invitrogen) and goat anti–rat (Invitrogen) secondary 
antibodies conjugated with Cy3 or Alexa Fluor 488 were used. Nuclei were 
stained with DAPI (OCHEM). The images were acquired using a fluorescence 
microscope (BX61; Olympus).
Histochemistry
NADH, SDH, COX, costaining of NADH and COX, Masson’s trichrome, 
and Gomori’s modified trichrome were performed on 10-µm biopsy frozen 
sections to evaluate histology and mitochondrial enzymatic activities 
(Dubowitz and Sewry, 2007). Murine gastrocnemius 10-µm sections (n = 3 
muscles per group) were stained following a standard Van Gieson protocol 
(Dubowitz and Sewry, 2007). A minimum of nine nonoverlapping images 
were analyzed in ImageJ for the percentage of connective tissue per field 
of muscle tissue.
Drug treatment of mdx and WT asynchronous remodeling mice
Drug-treated mdx mice were from the previously reported preclinical trial 
comparing 4 mo of 5 mg/kg/d prednisone treatment to 15 mg/kg/d 
VBP15 treatment (Heier et al., 2013). Frozen archival muscle samples 
were obtained for WT, mdx untreated, and the two drug-treated groups 
(prednisone and VBP15). RNA was isolated, and mRNA profiling was per-
formed using Illumina bead arrays, according to the manufacturer’s protocol 
(n = 5 per group). Bioinformatics analyses were performed using TGF- path-
way candidates. Drug treatment of the WT asynchronous remodeling mice 
(n = 5 per group) was performed using the same drugs and treatment regimens 
(5 mg/kg/d prednisone; 15 mg/kg/d VBP15), with treatment starting the 
day before the first surgery until the day before euthanasia.
Microscopic image acquisition
All images were acquired using a microscope (BX61; Olympus), with U Plan 
S Apochromat 20×/0.75 NA dry objective, at room temperature. Photog-
raphy was performed using a camera (DP11; Olympus) with DP controller 
3.2.1.276 and DP Manager 3.1.1.208 software.
Online supplemental material
Fig. S1 shows a flow chart of the data integration and biochemical net-
work analysis on the 12-group human muscle transcriptional profiling data. 
Fig. S2 shows LCM methods and chip clustering of mRNA profiles of LCM 
regions of multiply injured muscle. Fig. S3 shows quantitative analysis of 
endomysial fibrosis in asynchronous remodeled muscle samples. Fig. S4 
shows histochemical stains for mitochondrial activity showing a relative loss 
of mitochondrial oxidative phosphorylation in the area between injuries 
spaced 4 d apart. Fig. S5 shows treatment of asynchronous remodeling 
mouse muscle with prednisone or VBP15 suppresses the proinflammatory 
proteins in between injuries spaced by 4 d. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.201402079/DC1.
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surgically exposed, and the initial injection was made distally to proximally 
along the axis of the muscle. The wound was closed for the number of days 
indicated, and then, the second injection was performed after the time an-
notated in each experiment. The initial injection site could be visualized in 
the muscle as a result of the tattoo dye, and the second injection was initiated 
adjacent the first site. Mice were euthanized 13 d after the second injury, 
and gastrocnemii were collected.
For drug treatments with 5 mg/kg/d prednisolone, 15 mg/kg/d 
VBP15, or vehicle, the drug was delivered in sugar syrup orally. We had 
five mice in each group. Drug treatments were started 24 h before the initial 
notexin injection and then continued daily until sacrifice.
Van Gieson measures of fibrotic tissue
Reinjured muscle sections were stained by the Van Gieson method (n = 4 
muscles per group). Images were taken and analyzed with ImageJ (National 
Institutes of Health) to measure the extent of the connective tissue. We as-
sayed the amount of connective tissue per field of tissue by measuring the 
number of pixels occupied by red staining and then measuring the number 
of pixels covered by the muscle tissue. The data are then represented as the 
percentage of muscle that is collagenous connective tissue.
Laser capture microdissection
Flash-frozen muscle biopsies or specimens were sectioned at 10-µm thick-
ness on RNase-free glass slides (CellCut; Molecular Machines & Industries, 
Inc.). Slides were immediately placed in 99% ethanol to fix. Rapid hematox-
ylin and eosin stain using RNase-free solutions (Molecular Machines & Indus-
tries, Inc.) was then performed followed by laser capture microdissection 
(CellCut Plus instrument) to identify and cut the areas of interest. We used 
tubes with an adhesive cap to collect LCM-isolated regions (Molecular 
Machines & Industries, Inc.).
In brief, 15 consecutive sections for mice at 4 and 10 d were sub-
jected to LCM to isolate each region on each muscle, and cRNA amplifica-
tion was performed from the combined sections. 3–4 of the 15 LCM sections 
(per area per mouse) were successful in mRNA profiling, and these showed 
excellent chip-based clustering. Although the LCM was performed on only 
one mouse for 4 d and one mouse for 10 d (in part because of the need to 
identify closely spaced tattoo dye injection sites), additional mice were used 
for immunostaining validations.
LCM mRNA profiling
RNA isolation was performed using PicoPure kit (Applied Biosystems), which 
includes on-column DNase digestion. Two rounds of T7-mediated cRNA am-
plification were performed (RiboAmp HS kit [Applied Biosystems] and then 
TotalPrep-96 RNA Amplification kit [Life Technologies]). The mRNA profiling 
on asynchronous mouse LCM experiments was performed in triplicate on se-
rial sections. Murine WG-6 v2.0 Expression BeadChips (Illumina) contain-
ing 45,200 transcript probes or HumanHT-12 v4 Expression BeadChips 
(Illumina) containing 47,000 transcript probes were used. Results of expres-
sion arrays were read using the HiScan SQ System (Illumina). Statistical 
analyses (P ≤ 0.05 with correction for multiple testing [False Discovery Rate]) 
and a fold change ≤1.5 or ≥1.5) were performed to identify dysregulated 
genes in the areas of interest using Partek Genomics Suite software (Partek, 
Inc.). IPA was used to query protein–protein and gene–protein interactions.
TaqMan gene expression assay
The RiboAmp HS kit was used to perform two rounds of amplification on 
total RNA isolated from LCM samples (n = 3 muscles per group) and con-
vert amplified RNA to cDNA. Quantitative gene expression analysis was 
performed by TaqMan-based qRT-PCR on a real-time PCR system (7900 HT 
Fast; Applied Biosystems). We used TaqMan Gene Expression kits obtained 
from Applied Biosystems to run qRT-PCR: Cox6b1 (Mm00824357_m1), 
Ndufs6 (Mm02529639_u1), Ndufb5 (Mm00452592_m1), Ndufb6 
(Mm01208591_g1), and HPRT (hypoxanthine guanine phosphoribosyl-
transferase; Mm01318747_g1). The expression of HPRT was analyzed as 
endogenous control simultaneously, and the target gene expression in each 
sample normalized to HPRT. Thermal cycling conditions were 95°C for 
10 min, 50 cycles at 95°C for 15 s, and 60°C for 1 min.
Immunostaining
Monoclonal rat anti–mouse CD11b (eBioscience), mouse anti–human CD74 
(Abcam), mouse anti–human macrophage surface antigen (AM-3K/CD163), 
mouse anti–human mannose receptor (CD206; Abcam), and mouse anti–
human MMP9 (Santa Cruz Biotechnology, Inc.) monoclonal primary antibod-
ies were used to perform immunofluorescence assays. The Mouse on Mouse 
kit (Vector Laboratories) was used to reduce background staining when using 
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